Powder -20℃ 3 years; 4℃ 2 years In solvent -80℃ 6 months;-20℃ 1 month
研究领域:
Cancer
描述:
WHI-P180 is a multi-kinase inhibitor, which inhibits RET, KDR and EGFR with IC50s of 5 nM, 66 nM and 4 μM, respectively. WHI-P180 (AZ1) also acts as an inhibitor of tau-tubuline kinase 1 (TTBK1).